More than 80% of data from clinical trials conducted in China are fraudulent (see BMJ report HERE), after objective technical failures were found in 1,308 out of 1,622 trials that evaluated new drugs. A report released by China’s State Food and Drug Administration on 9th September last year found widespread fraud, and described the situation as chaotic as regards clinical trials conducted by the country’s pharmaceutical companies.

Image APRO